-
Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (ceftobiprole)
16 Dec 2024 12:22 GMT
… Pharmaceutica Ltd, Allschwil (SIX: BSLN), for the commercialization of Zevtera® (ceftobiprole … of differentiated treatments that address substantial unmet medical needs,” … and Drug Administration (FDA) approved Zevtera for three specific treatment indications …
-
Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United States
16 Dec 2024 06:15 GMT
… There is a significant medical need for treatments targeting complicated Staphylococcus … of Zevtera drug product from Basilea. About Zevtera® (ceftobiprole medocaril sodium … for the treatment of uncomplicated gonorrhea, and La Jolla Pharmaceutical Company, …
-
FDA Approves Ceftobiprole Medocaril Sodium for 3 Indications
14 Oct 2024 19:53 GMT
… FDA approved ceftobiprole medocaril sodium for injection (Zevtera) for the treatment … the phase 3 ERADICATE trial (NCT03138733) vs daptomycin. … drug. The primary outcome looked at overall treatment … Two phase 3 trials evaluated ceftobiprole for the CABP …
-
Drug Trials Snapshots: ZEVTERA
25 Sep 2024 22:38 GMT
… ceftobiprole medocaril sodium for injection)
Zev-Tair-a
Basilea Pharmaceutica … in the clinical trials?
The FDA approved ZEVTERA … drugs, vaccines, other therapies, or new ways of using existing treatments … trial.
PLACEBO: An inactive substance or “sugar pill” …
-
Staphylococcus aureus Bacteremia Market to Reach New Heights in Growth by 2034, DelveInsight Predicts
22 Jan 2025 20:41 GMT
… Pharmaceuticals, Inc. (NYSE American: ARMP), a clinical-stage biotechnology … aureus Bacteremia Drugs Uptake and … Companies
• Ceftobiprole: Basilea Pharmaceuticals
• AP-SA02: Armata Pharmaceuticals, Inc. … Bacteremia Current Treatment and Medical Practices
10 …
-
A Study Table To Help You Compare Fifth-Generation Cephalosporins: Ceftaroline Versus Ceftobiprole
01 Jul 2024 04:59 GMT
… Pharmaceutica’s ceftobiprole was granted approval by the FDA … 3 trials that gave ceftobiprole its FDA- … beta-lactamase; FDA = Food and Drug Administration; IAI … trial comparing ceftobiprole medocaril. With ceftriaxone with or without linezolid for the treatment …
-
Basilea sells rights to microtubule drug to Glioblastoma Foundation
20 Jun 2024 16:22 GMT
… Drug Administration orphan drug designation in 2021 for the treatment … 47;II trial (NCT02490800) readout, the Swiss pharmaceutical company decided … forward to initiating clinical trials of lisavanbulin in … partner for its antibiotic ceftobiprole.
Sign up for …
-
Sepsis Market Report 2034: Latest FDA, EMA, PDMA, Pipeline Therapies, Epidemiology
10 Jun 2024 12:52 GMT
… Biotechnologies, Inc.
• Ceftobiprole medocaril: Basilea Pharmaceutical
• VBI-S: Vivacelle Bio
Sepsis Drugs … FDA clearance to enroll patients into a Phase IIa clinical trial … Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. …
-
Drug Topics Top 10: Most Read Stories From April 2024
01 May 2024 00:23 GMT
… Investigator with the Drug Enforcement Administration … mount.
FDA Approves Antibiotic Ceftobiprole Medocaril … ceftobiprole medocaril sodium for injection (Zevtera) for 3 indications: the treatment … Treatment
After a long hiatus, research in psychedelic medicine …
-
April 2024 FDA Breakthroughs: Vaccine Approvals, PDUFAs, and More
30 Apr 2024 13:47 GMT
… providers can order the vaccine through wholesalers and distribution … health clinics.
The FDA approved Zevtera (ceftobiprole medocaril sodium for … and only oral, 2-drug, single-tablet regimen available … of Severe Illness, a trial which is evaluating a …